Self-Management Teaching Plan
Self-Management Teaching Plan
Training consisted of three consecutive weekly sessions (60-90 minutes each) for a group of 3-6 patients.
Session One
• Discuss general anticoagulation information.
• Teach self-monitoring using whole blood prothrombin time/international normalized ratio (PT/INR) monitor.
• Encourage subjects to measure INR values routinely during first week and to record INR results and anticoagulant dosage in logbook.
• Check subjects’ quality of INR value self- monitoring at session end.
Session Two
• Check subjects’ quality of INR self-monitoring at beginning of session.
• Discuss prevention of bleeding and thromboembolic complications.
• Discuss effect of diet on anticoagulation control.
• Discuss effect of additional medication on anticoagulation control.
• Provide instructions about indications for changing anticoagulation medication and protocols for reducing or increasing anticoagulation medication to achieve desired INR targets.
• Explain and monitor practice exercises completed by subjects.
Session Three
• Check subjects’ quality of INR self-monitoring at beginning of session.
• Reinforce instructions about indications and protocols for reducing/increasing anticoagulation medication to achieve desired INR targets.
• Discuss examples of adapting drug dosage and practice exercises completed by subjects.
• Discuss possible problems resulting from surgery, illness, exercise, pregnancy, and travel.
• Encourage subjects to control INR values by self-monitoring 1-2 times per week and to adjust the anticoagulation medication dose accordingly.
• Remind subjects to contact the teaching center if they encounter problems.
After completing the program, participants were expected to estimate their INR value with a deviation of less than 0.4 from the reference INR measurement. If they could not, the training program was repeated.
Source: Sawicki PT, for the Working Group for the Study of Patient Self-Management of Oral Anticoagu lation. A structured teaching and self-management program for patients receiving oral anticoagulation. JAMA 1999;281:146.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.